Olivier Donzé Selected Research

Tumor Necrosis Factor Ligand Superfamily Member 13

1/2021

APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Olivier Donzé Research Topics

Disease

1	Atherosclerosis 01/2021
1	Atherosclerotic Plaque (Atheroma) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Glucose Intolerance 01/2017
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 02/2016
1	Colorectal Neoplasms (Colorectal Cancer) 02/2016
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2016
1	Neoplasms (Cancer) 02/2016
1	Hyperplasia 01/2016
1	Ectodermal Dysplasia (Aplasia Cutis Congenita) 02/2014
1	Infections 04/2010
1	Virus Diseases (Viral Diseases) 04/2010
1	Chronic Hepatitis C 04/2010
1	Mastocytoma 12/2007

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 01/2016 - 02/2014
1	Tumor Necrosis Factor Ligand Superfamily Member 13IBA 01/2021
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2021
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2021
1	Heparitin Sulfate (Heparan Sulfate)IBA 01/2021
1	LipidsIBA 01/2017
1	Netrin-1IBA 02/2016
1	LigandsIBA 02/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	B-Cell Activating FactorIBA 01/2016
1	Blocking AntibodiesIBA 02/2014
1	EctodysplasinsIBA 02/2014
1	Monoclonal AntibodiesIBA 02/2014
1	Proteins (Proteins, Gene)FDA Link 04/2010
1	InterferonsIBA 04/2010
1	Antiviral Agents (Antivirals)IBA 04/2010
1	Interleukin-6 (Interleukin 6)IBA 12/2007
1	Interleukin-33IBA 12/2007